v3.25.4
Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Revenues        
Total Revenues $ 26 $ 24 $ 91 $ 93
Cost of revenues 0 2 0 5
Research and development expenses 1,140 1,780 3,064 4,166
Selling, general and administrative expenses 1,636 1,710 5,327 5,384
Total costs and expenses 2,776 3,492 8,391 9,555
Loss from Operations (2,750) (3,468) (8,300) (9,462)
Other Income (Expense)        
Interest income 63 26 231 129
Interest expense (4) (5) (8) (5)
Total Other Income 59 21 223 124
Income Tax Expense 0 0 (2) (2)
Net Loss (2,691) (3,447) (8,079) (9,340)
Other Comprehensive loss:        
Unrealized loss on available-for-sale debt securities 0 (1) 0 0
Comprehensive Loss $ (2,691) $ (3,448) $ (8,079) $ (9,340)
Net loss per common share basic $ (1.03) $ (2.28) $ (3.14) $ (6.6)
Net loss per common share diluted $ (1.03) $ (2.28) $ (3.14) $ (6.6)
Weighted average shares used in computing net loss per common share basic 2,607,962 1,504,713 2,572,331 1,409,423
Weighted average shares used in computing net loss per common share diluted 2,607,962 1,504,713 2,572,331 1,409,423
Royalty Revenue [Member]        
Revenues        
Total Revenues $ 26 $ 15 $ 91 $ 68
Product Revenue [Member]        
Revenues        
Total Revenues $ 0 $ 9 $ 0 $ 25